Metabolic Engineering of Escherichia coli for High-Level Production of Salicin
Lists
Only you see this
Abstract
Salicin is a notable phenolic glycoside derived from plants including <i>Salix</i> and <i>Populus</i> genus and has multiple biological activities such as anti-inflammatory and antiarthritic, anticancer, and antiaging effects. In this work, we engineered production of salicin from cheap renewable carbon resources in <i>Escherichia coli</i> (<i>E. coli</i>) by extending the shikimate pathway. We first investigated enzymes synthesizing salicylate from chorismate. Subsequently, carboxylic acid reductases (CARs) from different resources were screened to achieve efficient reduction of salicylate. Third, glucosyltransferases from different sources were selected for constructing cell factories of salicin. The enzymes including salicylate synthase AmS from <i>Amycolatopsis methanolica</i>, carboxylic acid reductase CARse from <i>Segniliparus rotundus,</i> and glucosyltransferase UGT71L1 from <i>Populous trichocarpa</i> were overexpressed in a modified <i>E. coli</i> strain MG1655-U7. The engineered strain produced 912.3 ± 12.7 mg/L salicin in 72 h of fermentation. These results demonstrated the production of salicin in a microorganism and laid significant foundation for its commercialization for pharmaceutical and nutraceutical applications.
BibTeX
@inproceedings{zhang2022metabolic,
author = {Mengqi Zhang and Chang Liu and Daoyi Xi and Huiping Bi and Zhanzhao Cui and Yibin Zhuang and Hua Yin and Tao Liu},
title = {{Metabolic Engineering of <i>Escherichia coli</i> for High-Level Production of Salicin}},
booktitle = {ACS},
year = {2022},
doi = {10.1021/acsomega.2c03347},
}Loading related content...